An unhealthy diet and an indolent life are well known causes of heart disease and stroke. But sleep apnea—where people ...

Losing weight, quitting smoking, and limiting alcohol can all help ease obstructive sleep apnea symptoms such as snoring. The ...

Sleep apnea at age 50 and over is linked to a higher risk of dementia- especially among women. The findings offer new insight into the role of sleep apnea on long-term cognitive health. The ...

Strategically, Vivos achieved notable milestones including receiving FDA clearance for its devices to treat moderate to severe obstructive sleep apnea in children, and the introduction of new medical ...

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

As Veterans Day approaches, those who served our nation face a quiet healthcare crisis. The Department of Veterans Affairs ...

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

Health Canada has now approved and provided a medical device licence for Apple’s sleep apnea notification feature. It works with one of the newer Apple Watch products: Apple Watch Series 9, Apple ...

Researchers have identified that children deficient in vitamin D experience more severe symptoms of obstructive sleep apnea ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

moderate and severe sleep apnea. Comparing data interpreted by the AI-based SOMNUM with expert readings of polysomnography, the study showed high sensitivity (95% CI: 98.06–98.51) and ...